FOR centuries, gout has been a deeply misunderstood disease, associated only with jolly, indulgent, and often big men. When Henry VIII was diagnosed, it became firmly entrenched in popular belief ...
Medically reviewed by Scott J. Zashin, MD Pain in the joint of your big toe is a fairly common issue that generally requires ...
In a significant milestone for Ayurvedic medicine, Amrith Noni has successfully completed human clinical trials for its ...
The NHS has listed what it believes to be the 20 top most painful conditions a person can suffer from. While there are ...
A recent study highlights a surprising issue for people living with gout in the United States: most gout flares are never ...
Supplements are widely used to manage joint pain, but the science on their effectiveness is limited. Here's what to know ...
The refractory gout market is growing because of the rising prevalence of gout brought on by aging populations and changes in ...
New treatments like dotinurad provide safer, more effective solutions for millions battling gout and hyperuricemia.
The global intravenous pegloticase market is poised for substantial growth, projected to reach USD 11.61 Billion by 2033 from ...
XORTX Therapeutics Inc. is a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease. The company is actively involved in creating ...
XORTX to focus on late stage allopurinol intolerant gout program; discussion with FDA planned for first half 2025 regarding ...